The topic of “Innovative Ecosystem Biotechnology” is one of its own in Germany. So is the extremely extensive regulatory regime. Both cultural assumptions such as the “innovation mindset” and historical perspectives still have a limiting effect. This shows that a considerable effort is required to keep up with the diversity of innovations internationally.
VC firm KIZOO — funded by Michael Greve, former co-founder of web.de — has adopted a new focus: Accelerating Rejuvenation Biotech.
1.
2.
3.
Subscribe newsletter
Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.